Illumina | ILMN

Stock Price
98.93
Daily Change
1.25 1.28%
Monthly
4.77%
Yearly
-20.47%
Q3 Forecast
98.11

Peers Price Chg Day Year Date
Agilent 128.75 0.27 0.21% -6.04% Sep/05
Bio-Rad Laboratories 295.43 6.00 2.07% -10.48% Sep/05
Bruker 30.83 1.04 3.49% -51.84% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Charles River Laboratories 163.99 1.68 1.04% -12.63% Sep/05
Quest Diagnostics 183.49 3.38 1.88% 20.12% Sep/05
Danaher 200.21 1.18 0.59% -24.77% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Exact Sciences 53.81 2.40 4.67% -8.97% Sep/05
Standard Biotools 1.30 0.01 0.78% -32.99% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Illumina 98.93 1.25 1.28% -20.47% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
Intuitive Surgical 466.86 12.34 2.72% -1.06% Sep/05
Laboratory Of America 278.67 3.44 1.25% 24.30% Sep/05
Mettler Toledo International 1,305.71 17.92 1.39% -5.26% Sep/05
Myriad Genetics 6.61 -0.18 -2.65% -75.49% Sep/05
Revvity 86.64 0.94 1.10% -24.90% Sep/05
Quidel 28.68 0.89 3.20% -33.99% Sep/05
Repligen 124.56 3.98 3.30% -15.31% Sep/05
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
Bio Techne 54.41 1.49 2.82% -24.00% Sep/05
Thermo Fisher Scientific 492.60 3.11 0.64% -19.59% Sep/05
Waters 306.32 6.63 2.21% -6.72% Sep/05
Dentsply International 14.62 0.29 2.02% -42.75% Sep/05

Indexes Price Day Year Date
USND 21700 -7.31 -0.03% 30.01% Sep/05
US100 23652 19.43 0.08% 28.40% Sep/05

Illumina traded at $98.93 this Friday September 5th, increasing $1.25 or 1.28 percent since the previous trading session. Looking back, over the last four weeks, Illumina gained 4.77 percent. Over the last 12 months, its price fell by 20.47 percent. Looking ahead, we forecast Illumina to be priced at 98.11 by the end of this quarter and at 95.69 in one year, according to Trading Economics global macro models projections and analysts expectations.

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.